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Abstract
Mucus secretion and mucociliary clearance are crucial processes required to maintain pulmonary 
homeostasis. In the trachea and nasal passages, mucus is secreted by submucosal glands (SMGs) 
that line the airway, with an additional contribution from goblet cells of the surface airway 
epithelium. The SMG mucus is rich in mucins and antimicrobial enzymes. Defective tracheal 
SMGs contribute to hyper-secretory respiratory diseases, such as cystic fibrosis, asthma, and 
chronic obstructive pulmonary disease, however little is known about the signals that regulate their 
morphogenesis and patterning. Here, we show that Fgf10 is essential for the normal development 
of murine tracheal SMGs, with gland development arresting at the early bud stage in the absence 
of FGF10 signalling. As Fgf10 knockout mice are lethal at birth, inducible knockdown of Fgf10 
at late embryonic stages was used to follow postnatal gland formation, confirming the essential 
role of FGF10 in SMG development. In heterozygous Fgf10 mice the tracheal glands formed but 
with altered morphology and restricted distribution. The reduction in SMG branching in Fgf10 
heterozygous mice was not rescued with time and resulted in a reduction in overall tracheal mucus 
secretion. Fgf10 is therefore a key signal in SMG development, influencing both the number of 
glands and extent of branching morphogenesis, and is likely, therefore, to play a role in aspects of 
SMG-dependent respiratory health.
Keywords: Branching morphogenesis, development, airway, fibroblast growth factor, respiratory 
disease
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Introduction
Airway mucus secretion plays a critical role in the muco-ciliary clearance of billions of airborne 
particles and pathogens daily. Respiratory mucus is produced by the goblet cells of the surface 
epithelium and the submucosal glands (SMGs) found within the submucosal layer of the nasal, 
tracheal and bronchial cavities (Sturgess & Imrie 1982; Borthwick et al. 1999; May & Tucker 
2015). The structure of tracheobronchial SMGs are characterized into three domains: (1) the distal 
secretory gland, (2) the medial collecting duct and (3) the proximal ciliated duct (reviewed in May 
& Tucker 2015). The distal region consists of two distinct secretory cell types, responsible for 
producing airway mucus. Serous cells produce a solution primarily consisting of mucin MUC7, 
proteoglycans and bactericidal proteins such as lactoferrin and lysozyme (Masson et al. 1966; 
Klockars & Reitamo 1975; Finkbeiner 1999) while mucous cells produce a gel rich in MUC2 and 
MUC5b and antimicrobial peptide cathelicidin (Buisine et al. 1999; Finkbeiner 1999). Collectively 
these secretions provide a barrier to the exposed surface airway epithelium. While the cellular 
composition of SMGs is homologous across mammals, SMG distribution can change between 
species. In mice, respiratory SMGs are found within the walls of the nasal cavity and extend to the 
upper trachea, with most tracheal SMGs found between the cricoid cartilage and the first tracheal 
cartilage ring. SMGs in mice only extend to the seventh cartilage ring, however in humans glands 
extend more caudally throughout the trachea and bronchi (Borthwick et al. 1999; Sturgess & Imrie 
1982).
The need to understand the morphogenesis, structure and function of the SMGs is emphasised by 
the role they play in respiratory diseases such as cystic fibrosis (CF), asthma and chronic 
obstructive pulmonary disease (COPD). Decreased mucus secretion from tracheal and nasal SMGs 
is characteristic of humans with CF (Joo et al. 2010; Salinas et al. 2005; Jeong et al. 2015), 
contributing to decreased mucociliary clearance of the airways and onset of pulmonary infection. 
Further evidence in the pig model of CF shows that mucus hypo-secretion (Joo et al. 2010; Cho et 
al. 2011), and increased mucus tethering from the SMGs (Hoegger et al. 2014) give rise to hindered 
muco-ciliary clearance, prior to the onset of inflammation, indicative that SMG morphology and 
function are primary defects of CF pathogenesis. Mouse models of CF have shown to have 
abnormal distribution of tracheal SMGs, with an increase in proximal numbers of SMGs in 
diseased animals (Borthwick et al. 1999). Moreover, early onset of hypertrophy in SMGs is 
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characteristic of infants with CF (Oppenheimer & Esterly 1975; Sturgess & Imrie 1982). Chronic 
asthma sufferers also show signs of SMG secretory cell hyperplasia (Aikawa et al. 1992; Rogers 
2004), while sufferers of COPD show mucous cell hyperplasia that gives rise to mucus-
hypersecretion and airway plugging (Reid 1960; Rogers 2008).
Development of SMGs undergoes typical patterns common to other branching organs such as the 
lung, salivary gland and mammary gland (Tucker 2007; Hannezo et al. 2017). Tracheal SMG 
morphogenesis can be described in four stages (Keswani et al. 2011; Thurlbeck et al. 1961). Stage 
1 of development defines the specification and emergence of an initial gland bud from the 
respiratory epithelium (Figure 1, A). Stage 2 is characterised by elongation of the epithelial bud 
into the underlying mesenchyme, and the onset of cavitation within the stalk as lumen formation 
begins (Figure 1, A). Stage 3 describes the continual clefting and branching of the SMG, alongside 
lumen formation. Stage 4 is classified by cellular differentiation, indicated by mucus production 
within the distal glandular secretory cells (Figure 1, A). 
A few studies have shed light on the signalling pathways involved in tracheal SMG development 
and patterning. Eda/Edaradd expression is required for early gland initiation and budding as 
tracheal SMG number is severely reduced in both the Tabby (Eda mutant), and Crinkled mouse 
(Edaradd mutant) at postnatal day 7 (Rawlins & Hogan 2005). Furthermore, human patients with 
hypohidrotic ectodermal dysplasia, caused by defects in the EDA pathway, have reduced numbers 
of respiratory SMGs, asthma-like symptoms, and respiratory tract infections (Callea et al. 2013). 
Wnt/β-catenin activation of lymphoid enhancer factor Lef-1 is also required for early SMG bud 
specification and outgrowth (Xie et al. 2014). The transcription factor Sox2 inhibits expression of 
the Lef-1, while WNT signalling reduces Sox2 expression in the SMG placode. Therefore, WNT 
signalling leads to reduced SOX2 and an increase of Lef-1 transcripts in SMG placodes, suggesting 
a dynamic relationship between WNT signalling and Sox2 expression during SMG bud 
specification (Xie et al. 2014).
In vertebrates, fibroblast growth factors (FGFs) make up one of the largest family of polypeptide 
proteins with 22 ligands (FGF1-FGF22) and four cell membrane-bound FGF receptors 
(FGFRs)(Ornitz & Itoh 2001). FGF10/FGFR2b signalling is required for successful development 
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of many branched organs (Ohuchi et al. 2003). Lung morphogenesis is inhibited in the absence of 
Fgf10 and Fgfr2b expression, and Fgf10 and Fgfr2b homozygous mice die at birth due to lung 
agenesis (Sekine et al. 1999; Min et al. 1998; De Moerlooze et al. 2000). Morphogenesis of the 
submandibular salivary gland is arrested at the initial bud stage at embryonic day E12.5 in 
both Fgf10 and Fgfr2b homozygous (-/-) mice, and salivary glands are hypoplastic and secrete a 
reduced volume of saliva in Fgf10 heterozygous (+/−) adults (May et al. 2015). More recently it 
has been shown that Fgf10 maintains Sox9 expression and regulates SOX9+ epithelial progenitor 
cell expansion during salivary gland morphogenesis (Chatzeli et al. 2017). 
The tracheal SMGs have not been investigated in the complete absence of FGF10 signalling, 
however Fgf10 heterozygous mice have a reduction in the number of SMGs at postnatal day 20 
compared to wildtype littermates (Rawlins & Hogan 2005). The glands present in the tracheal 
submucosa had undergone less branching and were restricted to the anterior trachea, with no glands 
found between the more posterior cartilaginous rings (Rawlins & Hogan 2005). Considering this 
altered phenotype, we investigated the role of FGF10 in early tracheal SMG development using 
both knockout and conditional knockout mice. 
Materials and Methods
Experimental Animals
Fgf10-deficient mice were first generated by Min et al. (1998) (Mouse Genome Informatics ID 
1099809). Investigation was carried out on WT (n=3), Fgf10 +/- (n=2) and Fgf10 -/- (n=4) for P0 
SMG analysis and WT (n=7) and Fgf10 +/- (n=6) for adult SMG analysis. For inducible ablation 
experiments, the ubiquitous pCAGGCre-ERT2 allele (Hayashi and McMahon, 2002) was crossed 
to Fgf10 floxed (Fgf10A02 tmc1c) mice on a C57BL/6 background (produced by MRC-Harwell 
as part of the International Mouse Phenotyping Consortium (IMPC; Skarnes et al. 2011; Bradley 
et al. 2012). Fgf10fl/fl females were crossed to pCAGCre-ERT2/+;Fgf10fl/+ males to generate 
wildtype pCAGCre-ERT2+/+;Fgf10fl/fl (WT;Fgf10fl/fl, n=3), pCAGCr-eERT2/+;Fgf10fl/+ 
(CreERT2;Fgf10fl/+, n=3)  and  pCAGCre-ERT2/+;Fgf10fl/fl (CreERT2;Fgf10fl/fl, n=3) mouse pups 
which were collected at postnatal day (P)21. R26-tdTomato reporter line (Gt(ROSA)26 Sor 
tm14(CAG-tdTomato)Hze JAX labs) was used to confirm the activity of the Cre induced by 
tamoxifen and were mated to Fgf10fl/fl males to generate Fgf10fl/fl;R26RtdTom females. These 
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were mated to PCAGcreERT2/+;Fgf10fl/+ males and the Tomato was observed with a Nikon 
SMZ25 fluorescence microscope. Fgf10/lacZ/+ reporter mice carrying a nuclear-targeted lacZ 
insertion that does not disrupt Fgf10’s coding exons, were mated and postnatal pups were provided 
by Mohammad Hajihosseini (n = 3) (Kelly et al., 2001; Hajihosseini et al., 2008). All procedures 
and culling methods were performed under a project license approved by the United Kingdom’s 
Home Office and in accordance with the Animal (Scientific Procedures) Act of 1986, United 
Kingdom. 
Animal Collection
Mice were mated in the late evening and a midnight mating was assumed. Midday of the day at 
which a vaginal plug was discovered was recorded as embryonic day (E) 0.5. Adult males and 
females were culled by exposure to rising levels of CO2 gas. Primers used to detect wildtype Fgf10 
locus were 5’-GAGGAAATGCTGCGCACAATGTATACTCGG-3’ (Fgf203 forward primer) 
and 5’-GGATACTGACACATTGTGCCTCAGCCTTTC-3’ (Fgf204 reverse primer) while the 
mutant Fgf10 locus was detected by primers 5’-GCTTGGGTGGAGAGGCTATTC-3’ (Fgf233 
forward primer) and 5’-CAAGGTGAGATGACAGGAGATC-3’ (Fgf234 reverse primer) of the 
neo-cassette insert (Sekine et al. 1999). The inducible loss of Fgf10 was performed by 
administering 75mg of tamoxifen/kg body weight intraperitoneally in corn oil into E17.5 pregnant 
mice, and 15µg/g into each pup at postnatal day 2.  Corn oil injections alone has been shown to 
lead to no activation of this Cre line (Hayashi & McMahon, 2002). E17.5 was chosen as this is 24 
hours prior to the induction of SMG in the trachea (May & Tucker, 2015). Tamoxifen 
recombination time was expected to occur 24h after administration (Danielian et al., 1998). 
Tamoxifen was injected in combination with progesterone to counter the negative effects of 
tamoxifen on the ability to give birth naturally (Lizen et al., 2015). At this dose of tamoxifen the 
recombination of this Cre line is not 100% penetrant (Hayashi & McMahon, 2002). Therefore a 
second injection was given postnatally at P2. Mice were then culled at postnatal day 21. 
Histological Staining
Upon collection, trachea were fixed in 4% paraformaldehyde in PBS (PFA) overnight at 4°C. 
Tissue was dehydrated in increasing methanol concentrations and left overnight at 4°C in 
Isopropanol (Sigma Aldrich). Samples were cleared in 1,2,3,4 Tetrahydronaphthalene at RT, and 
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embedded in paraffin wax. Alternative serial 9μm sagittal sections were collected along 
dorsal/ventral axis of each trachea. Paraffin embedded sections were dewaxed using Histoclear 
and rehydrated through an ethanol series. Tracheal sections were stained using a Trichrome stain 
of 1% Alcian Blue, Ehrlich’s Haematoxylin and 0.5% Sirius Red in saturated Picric Acid.
X-gal staining of Fgf10 LacZ+/- postnatal submucosal glands
Trachea of postnatal day 7 (P7) were fixed in PFA 4% overnight at 4oC, followed by two washes 
in 2µM of magnesium chloride (MgCl2) in PBS for 5 and 15 minutes at RT. Samples were then 
washed in a solution of 0.1% of Deoxycholic Acid, 0.2% of Igepal NP-40, 1µM of MgCl2 in PBS 
for 5 minutes at RT. Staining was performed using previous solution with 5mM of K3Fe(CN)6, 
5mM of K4Fe(CN)6 and 1mg/mL of X-gal in Dimethyl sulfoxide (DMSO) overnight at 37oC. 
Samples were washed in PBS and post-fixed in PFA overnight at 4oC to stop reaction, followed 
by paraffin embedding process. Sections of 15µm were then counterstained in 0.5% of alcoholic 
eosin and mounted with Neomount (Merck Millipore).
Cartilaginous staining of embryonic tracheal tissue
Trachea were dissected from E18.5 Fgf10 WT and Fgf10 +/- littermates and fixed overnight in 
95% ethanol in deionised H2O at 4°C. After 24 hours of fixation, fat from tissue was removed by 
storing trachea in 100% acetone overnight at RT.  Followed by two rinses in 95% ethanol, trachea 
were placed in Alcian Blue solution (15mg Alcian Blue 8GX in 80ml 95% ethanol and 20ml glacial 
acetic acid) for 24 hours rocking at RT. Tissue was rinsed with 95% ethanol twice for 30 minutes 
and stored in 95% ethanol overnight at RT. Trachea were cleared in 1% Potassium Hydroxide 
(KOH) for 3-4 hours. Tissue went through a series of 1% KOH and glycerol solutions, at RT. 
Tissue was stored in 100% glycerol imaged using a Leica MZFLiii dissection microscope fixed 
with a Leica DFC300 Fx camera. 
Mucus secretion analysis
Mice aged 7-8 weeks (WT; n=4, Fgf10 +/-; n=6) were culled by exposure to rising levels of CO2 
and trachea were immediately dissected. The thyroid gland and oesophagus were removed, and 
the trachea was cut along the dorsal trachealis muscle (Supplementary Figure 1, A). The following 
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procedure was modified from the method used (Ianowski et al. 2007). Using insect pins, the trachea 
was opened and pinned to a sylgard plate and the luminal mucosal surface was exposed 
(Supplementary Figure 1, B). The mucosal side of each trachea was dried with air spray and 5µl 
of mineral oil (Sigma) was added to the surface. Beneath the trachea, 2.5µl of D-MEM/F12 plus 
penicillin/streptomycin and 1% Glutamax (Invitrogen) medium was added to nourish the tissue 
during incubation (Supplementary Figure 1, B). Tracheal tissue placed in a 95% O2: 5% CO2 
incubator at 37°C for 10 minutes. The exposed trachea was placed under a Leica MZFLiii 
dissection microscope fitted with a Leica DFC300 Fx digital camera.  A further 2.5µl of 
DMEM/F12 medium containing 60µM of the cholinergic carbachol (Sigma) was added to the 
medium bath, giving a final concentration of 30µM carbachol stimulating the tracheal glands. 
Photographs of the anterior region of the trachea were taken every 30 seconds for 10 minutes to 
trace mucus bubble production.
After 10 minutes of exposure to carbachol, the total number of mucus bubbles produced were 
counted. Viable bubbles for area measurement were those of which followed the criteria described 
in Ianowski et al. (2007): (a) a complete circular outline surrounding each mucus bubble as 
accurate measurements could be collected and (b) no fusion with adjacent droplets. For gland 
opening analysis these criteria were not followed, as they were not required to count the amount 
of bubbles produced.  Area of each bubble was calculated in micrometres (µm3) ImageJ software.  
Overall trachea mucus secretion was calculated by the sum of all areas of each bubble per animal.  
Statistics and graphs were calculated using Microsoft Excel and Graphpad Prism software.
Results
Complete loss of Fgf10 leads to defective tracheal SMG development
To investigate the role of Fgf10 during early stages of tracheal SMG development, glands were 
analysed in Fgf10 +/- and Fgf10 -/- mice. Although Fgf10 -/- mice die at birth due to lung agenesis 
(Min et al. 1998; Sekine et al. 1999), initiation of SMGs can be analysed as anterior glands start to 
emerge from the tracheal epithelium at Embryonic day (E)18.5 (May & Tucker 2015). Fgf10 
mutant pups were collected on E19/P (postnatal day) 0 as the mother was giving birth. In wildtype 
(WT) animals, glands had budded, elongated, cavitated and commenced branching (Figure 1, B, 
B’). Similar stages of development were seen in heterozygous (Fgf10 +/-) littermates however 
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gland development appeared delayed and branching of the formed glands reduced (Figure 1, C, 
C’). In the complete absence of Fgf10 in homozygous animals (Fgf10 -/-), some gland buds were 
found emerging from the surface epithelium, however development was arrested at this bud 
initiation stage, with no glands found at a distance from the tracheal surface (Figure 1, D. D’). This 
indicates that the SMGs did not undergo later stages of branching morphogenesis and that Fgf10 
expression is not required for initial epithelial gland bud specification but is required for 
subsequent successful bud elongation and branching.
Time inducible loss of Fgf10 during postnatal development reduces anterior tracheal SMG 
branching and posterior SMG expansion
To further investigate the role of Fgf10 during SMG morphogenesis, we turned to later stages of 
postnatal gland development. First, we analysed Fgf10 expression in Fgf10LacZ/+ mice at P7. Xgal 
staining revealed Fgf10 expression in the mesenchyme surrounding the developing SMG (Figure 
2, A). To follow development of the tracheal SMGs at postnatal stages we moved to a time 
inducible Fgf10 knockout mice (CreERT2;Fgf10fl/fl;tdTom). Tamoxifen was administered to 
pregnant females at E17.5, just as the most anterior tracheal SMGs were starting to initiate, and 
again to individual pups at P2, with tracheal tissue collected at P21 (Figure 2, B). As Fgf10 -/- 
mice die at birth, due to agenesis of the lungs (Sekine et al. 1999; Min et al. 1998), ablation of 
FGF10 using the inducible knockout mouse allowed pups to develop to E17.5 with adequate 
FGF10 expression, but permitted our continued study of SMG development in the absence of 
FGF10 from E18.5. Earlier injection was not attempted due to potential compromised development 
of the palate, which is reliant on Fgf10 expression (Rice et al. 2004; Teshima et al. 2016). 
Tamoxifen inducible Cre recombination was confirmed in the anterior and posterior trachea by the 
expression of R26tdTomato (red – Figure 2, C). No Tomato was observed in control Cre negative 
Fgf10fl/fl;tdTom pups (Figure 2, C). Trichrome staining of tracheal sections concluded a significant 
loss of anterior SMG branching adjacent to the cricoid cartilage in CreERT2;Fgf10fl/fl animals 
compared to control Cre negative littermates (Figure 2 D, orange outline). A slight reduction in 
anterior SMG branching was observed in heterozygous CreERT2;Fgf10fl/+ littermates (Figure 2, D).  
Additionally, an absence of SMGs located posterior to the cricoid cartilage, in between the tracheal 
cartilage rings was evident in both CreERT2;Fgf10fl/+ and CreERT2;Fgf10fl/fl  animals, while in control 
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mice SMGs reached the 4th cartilage ring (C4)(Figure 2 D-E). These results further support the 
necessity of Fgf10 in tracheal SMG elongation and branching. 
Anterior and posterior tracheal SMGs are reduced in Fgf10+/- adult mice
It has previously been reported that there is an altered SMG phenotype in adult Fgf10 +/- mice, 
with a reduction in branching of the anterior SMGs adjacent to the cricoid cartilage and a severe 
reduction in the posterior expansion of the glands between each tracheal cartilage ring in adult 
Fgf10 +/- (Rawlins & Hogan 2005). We investigated adult WT and Fgf10 +/- littermates and 
observed a similar phenotype in our mouse line with a reduction in anterior tracheal SMGs in 
heterozygous animals compared to their WT littermates (Figure 3, A). Variation in severity of this 
reduction was observed in Fgf10+/- mice however the number of glands was always decreased in 
the heterozygous adults compared to WT littermates (Figure 3, A and B). Analysis of SMGs 
between tracheal cartilage rings also showed a notable reduction in the anterior-posterior presence 
of the glands (Figure 3, B). The majority of WT littermates showed continuous SMG development 
between each cartilage ring, most often reaching the mesenchyme between the 6th and 7th ring 
(Figure 3, B). In Fgf10 +/- mice, posterior expansion of the SMGs was significantly reduced, with 
small SMGs only found above the 3rd cartilage ring. In a previous study investigating tracheal 
SMG formation in the Tabby mouse, which has deficient Eda signalling, the pseudostratified 
epithelium of the trachea showed a disorganized appearance and increased height of columnar 
epithelial cells compared to WT animals (Rawlins & Hogan 2005). In our study, no epithelial 
abnormalities were observed in the Fgf10 +/- animals compared to their WT littermates (Figure 3, 
C). 
Fgf10 has been shown to be expressed in the ventral tracheal mesenchyme from E12.5-E16.5 when 
tracheal patterning is underway (Sala et al. 2011). Additionally,  Fgf10 null embryos have 
truncated trachea with disorganized rings (Sala et al. 2011). As SMGs form between the tracheal 
cartilage rings, we wanted to ensure that the observed altered SMG phenotype in Fgf10 +/- animals 
was not a secondary defect to abnormal cartilage patterning. This hypothesis was ruled out using 
whole mount Alcian Blue staining, however, as no difference in cartilage phenotype between WT 
and Fgf10 +/- littermates was observed (Supplementary Figure 1, A).
Fgf10 +/- adult mice showed reduced tracheal SMG openings and overall mucus secretion
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Using histological methods, it was difficult to conclude whether the heterozygous mice showed a 
reduction in branching of each gland, a reduction in the number of glands within the anterior 
mesenchyme, or collectively both of these mechanisms. We therefore moved to a live tracheal 
explant model to follow mucous production. Previous papers have used the application of mineral 
oil to the mucosal tracheal surface to investigate SMG fluid secretion (Joo et al. 2001; Ianowski et 
al. 2007). We therefore used this model to assess whether the defect in branching led to a reduction 
in the amount of mucus secreted into the airway lumen in heterozygous animals compared to their 
WT littermates (Supplementary Figure 1, B and C). A time line of images was taken of the tracheal 
tissue in culture during mucus production stimulated by carbachol over a 10-minute period. Images 
were analysed and the number of mucus bubbles present between the cricoid cartilage (CC) and 
Tracheal cartilage 2 (C2) were counted.  Each bubble represented the presence of a gland opening. 
Results elucidated that the amount of bubbles was significantly reduced in Fgf10 +/- animals 
(p<0.001), indicating a decrease in the number of functional glands within the mesenchyme of the 
trachea between the anterior cartilage rings in Fgf10 +/- adults (Figure 4, A and B). While analysis 
of the area of each individual bubble did not differ significantly between the two groups (p=0.429), 
the overall amount of mucus secreted (sum of all bubble areas) was significantly reduced in Fgf10 
+/- adults (Figure 4, B, p<0.001). Together with the histological analysis of Fgf10 heterozygous 
adult mice, these results indicate a reduction in total mucus secreted within the tracheal lumen 
compared to WT littermates, which is due to a combination of both reduced gland number and 
reduced gland branching.
Discussion
The present study takes a number of approaches to show that Fgf10 signalling is essential for the 
development of tracheal submucosal glands. Our results conclude that although SMG bud 
initiation and outgrowth may be Fgf10 independent, the later stages of gland branching, cellular 
differentiation and gland secretion are significantly compromised in the absence of Fgf10 
expression. 
As anterior tracheal SMGs in the ventral part of the tube start initiating at E18.5 in our mouse line, 
this gave us an opportunity to collect Fgf10 -/- pups at P0, along with their WT and Fgf10 +/- 
littermates, to investigate the effect of loss of Fgf10 on gland initiation. Interestingly, gland buds 
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were found in the ventral and slightly more dorsal anterior positions in the Fgf10 -/- specimens 
collected. This result showed that Fgf10 is not required for the initiation of the epithelial gland 
primordia or the outgrowth of the initial gland bud, however it is essential for glands to progress 
to later development. The role of FGF10 in these later morphogenetic stages was further supported 
by a reduction in SMG branching observed in Fgf10 +/- pups at P0. Ventral glands of WT animals 
had reached the lumen formation stage and were undergoing clefting and branching while Fgf10 
+/- littermates displayed glands that had elongated into the underlying mesenchyme and formed 
lumens but showed evident reduced branching. This phenotype mirrors that reported for both the 
submandibular salivary gland (Jaskoll et al. 2005; Wells et al. 2013; Teshima et al. 2016; Chatzeli 
et al. 2017) and mammary gland (Mailleux et al. 2002) in Fgf10 -/- mice, where gland development 
does not progress passed the bud stage and branching is reduced leading to aplastic glands. This 
suggests that FGF10 signalling in particular is not needed for initial gland outgrowth, a conserved 
role reported in a variety of glandular organs, but is essential for subsequent development stages 
and that other ligands are essential for initial gland budding. One such factor may be FGF7, which 
also signals through FGFR2b. Ex vivo studies of the developing submandibular salivary gland have 
shown that FGF7, through activated MEK and PI3K signalling cascades, is required for salivary 
gland budding, and that FGF10 promotes branching and elongation of gland ducts through MEK 
1/2 signalling (Steinberg et al., 2005). Furthermore, both recombinant human FGF7 and FGF10 
induce ectopic bud formation of the lacrimal gland epithelium in mouse embryonic ocular cultures 
(Makerenkova et al., 2000). This suggests that FGF7 may promote SMG initial bud formation, or 
even compensation in the absence of FGF10 signalling to induce SMG bud outgrowth. 
Furthermore, we previously showed that Fgf10 expression is essential for a subset of nasal glands, 
with other Fgfs compensating for the loss of Fgf10 in some glands (May et al. 2016). The lateral 
nasal glands, for example, only require Fgf10 for later gland branching stages, while the Steno’s 
gland and the sinus glands require Fgf10 expression earlier at gland initiation stages (May et al. 
2016). The SMGs therefore show a reliance on FGF10 signalling more similar to the stenos and 
sinus glands. 
As previously reported in other glands (May et al. 2016; Chatzeli et al. 2017), here we show that 
Fgf10 is expressed in the tracheal mesenchyme adjacent to the gland epithelium during branching 
morphogenesis at P7. Due to agenesis of the lungs, Fgf10 -/- mice die at birth (Sekine et al. 1999; 
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Min et al. 1998), thereby preventing the study of later stages of tracheal gland development in the 
null mutant. Therefore, we adopted the use of a conditional Fgf10 ablation model to investigate if 
tracheal SMGs could develop postnatally in the absence of FGF10 signalling. Ablation of Fgf10 
was induced at E17.5 and P2 and tracheal tissue was collected at P21. Histological analysis 
revealed a significant reduction in branching of the anterior glands adjacent to the cricoid cartilage 
in CreERT2;Fgf10fl/fl mice compared to wildtype littermates. Although minimal, some branching 
and cellular differentiation (indicated by mucus staining - blue) had occurred in the anterior gland 
epithelia. As our first tamoxifen administration may have taken 24 hours to induce Cre-
recombination, some residual FGF10 may have promoted branching and mucus production in few 
SMG primordia that had initiated by E17.5/E18.5. Furthermore, as 100% Cre-recombination 
cannot be guaranteed, again some SMG placodes may have been exposed to low levels of FGF10, 
inducing some cellular differentiation. To this end, mucus cell differentiation was indicated by 
alcian blue staining alone and to conclude the role of FGF10 in cellular differentiation, analysis of 
differentiation markers such as AQP5 (Song et al., 2001) and MUC5b (Roy et al., 2014) is 
required. In contrast, posterior SMGs that develop postnatally were reduced in CreERT2;Fgf10fl/+ 
mice and completely absent in CreERT2;Fgf10fl/fl mice at P21, while found to extend to C4 in WT 
littermates. This phenotype suggests one of two strategies: (1) bud outgrowth had occurred, 
however loss of Fgf10 caused cell death in gland epithelium leading to no SMG buds evident by 
P21; or (2) FGF10 is required for gland initiation and bud outgrowth in more posterior SMGs. In 
support of the latter, heterogeneous progenitor cell populations and signalling mechanisms are 
known to occur in the lung epithelium in an anterior/posterior axis. Cytokeratin-5 positive basal 
cells replenish the airway epithelium in the anterior trachea (Rock et al. 2009), while Clara cells 
are understood to be the main stem cell population of the more posterior tracheal epithelium 
(Rawlins et al. 2009). More recently, a study investigating airway epithelial regeneration following 
severe injury showed a multipotent SMG myoepithelial progenitor replenished airway epithelium 
in the anterior trachea (between CC-C1), with reduced replenishment observed in the posterior 
epithelium (C1-C4)(Lynch et al. 2018). Considering these heterogeneous mechanisms, while 
FGF10 may not be essential for anterior SMG bud initiation, it may be required for bud outgrowth 
in more posterior glands. This may also explain the phenotype observed in adult Fgf10 +/- mice, 
where the posterior glands are more strongly affected. It is understood that mesenchymal FGF10 
regulates progenitor cell proliferation in adjacent branching epithelial structures in a number of 
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different organs, such as the lung (Ramasamy et al. 2007), pancreas (Bhushan et al. 2001) and 
salivary gland (Chatzeli et al. 2017). For example, analysis of PCNA positive cells during lung 
development with reduced FGF10 signalling revealed a significant decrease in proliferating cells 
in the lung epithelium, while proliferation was unchanged in the mesenchyme population 
(Ramasamy et al. 2007). Further analysis of cell proliferation in both the anterior and posterior 
trachea will give insight into the role of FGF10 in regulating this process in tracheal SMGs. 
Furthermore, the altered SMG phenotype in the conditionally ablated Fgf10 model, and the global 
Fgf10 heterozygous mouse is similar to the aplastic lacrimal and salivary gland phenotypes 
observed in patients that suffer from both ALSG and LADD syndrome (Milunsky et al. 2006; 
Shams et al. 2007; Entesarian et al. 2007). While no reports have stated any pulmonary defects in 
patients with ALSG or LADD syndrome, the airway SMGs may show aplasia and this phenotype 
could possibly give rise to muco-ciliary deficiencies in those that suffer from these autosomal 
dominant diseases. Furthermore, our functional tests of mucus secretion in Fgf10 +/- adult mice 
conclude a significant reduction in total amount of mucus secreted into the airway lumen. As only 
the anterior glands were included in the study, an even greater difference would be assumed if all 
mucus bubbles extending posteriorly in WT animals had been calculated. 
In addition, previous reports have indicated SMG development has ended by P21 in the mouse 
trachea (Rawlins and Hogan, 2005). However, in our analysis, WT mice only had SMGs extending 
down to the 4th tracheal cartilage ring (C4) at P21, in comparison to the 6-8 week WT mice where 
glands were observed at much more posterior levels (Figure 3, B). We therefore believe that 
posterior initiation of glands still occurs after 3 weeks. To this end, we report that tracheal 
mesenchymal Fgf10 expression is essential for tracheal submucosal gland morphogenesis, in both 
late embryonic and early postnatal stages. Without this signalling factor, glands fail to develop, 
arresting at the bud stage anteriorly. Investigation into this developmental signalling cascade 
should be considered in further research attempting to understand the role of these organs in hyper-
secretory respiratory diseases.
Acknowledgements
We would like to thank the Dental Institute of King’s College London (Tucker, 2011) for funding 
May AJ. Teshima THN was funded by FAPESP (Fundação de Amparo à Pesquisa do Estado de 
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
São Paulo) (grant 2015/02824). Thanks to Mohammad Hajihosseini (University East Anglia) for 
the Fgf10LacZ reporter mice. The Fgf10A02 tmc1c mice were obtained from the MRC-Harwell, 
which distributes these mice on behalf of the European Mouse Mutant Archive 
(http://www.emmanet. org). The MRC-Harwell is also a member of the International Mouse 
Phenotyping Consortium (IMPC), which funded the generation of the Fgf10A02 tmc1c mice. 
Associated primary phenotypic information may be found at http://www. mousephenotype.org.
References
Aikawa, T. et al., 1992. Marked goblet cell hyperplasia with mucus accumulation in the airways 
of patients who died of severe acute asthma attack. Chest, 101(4), pp.916–21.
Bhushan,  a et al., 2001. Fgf10 is essential for maintaining the proliferative capacity of epithelial 
progenitor cells during early pancreatic organogenesis. Development, 128(24), pp.5109–
5117.
Borthwick, D.W. et al., 1999. Murine submucosal glands are clonally derived and show a cystic 
fibrosis gene-dependent distribution pattern. American Journal of Respiratory Cell and 
Molecular Biology, 20(6), pp.1181–9.
Bradley, A. et al., 2012. The mammalian gene function resource: The International Knockout 
Mouse Consortium. Mammalian Genome, 23(9–10), pp.580–586.
Buisine, M.P. et al., 1999. Developmental mucin gene expression in the human respiratory tract. 
American journal of respiratory cell and molecular biology, 20(2), pp.209–218.
Callea, M. et al., 2013. Ear nose throat manifestations in hypoidrotic ectodermal dysplasia. 
International Journal of Pediatric Otorhinolaryngology, 77(11), pp.1801–4.
Chatzeli, L., Gaete, M. & Tucker, A.S., 2017. Fgf10 and Sox9 are essential for the establishment 
of distal progenitor cells during mouse salivary gland development. Development, 144(12), 
pp.2294–2305.
Cho, H.-J., Joo, N.S. & Wine, J.J., 2011. Defective fluid secretion from submucosal glands of 
nasal turbinates from CFTR-/- and CFTR (ΔF508/ΔF508) pigs. N. Vij, ed. PloS one, 6(8), 
p.e24424.
Danielian, P.S. et al., 1998. Modification of gene activity in mouse embryos in utero by a 
tamoxifen-inducible form of Cre recombinase. Current biology : CB, 8(24), pp.1323–1326.
Entesarian, M. et al., 2007. FGF10 missense mutations in aplasia of lacrimal and salivary glands 
(ALSG). European Journal of Human Genetics, 15(3), pp.379–82.
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
Finkbeiner, W.E., 1999. Physiology and pathology of tracheobronchial glands. Respiration 
Physiology, 118(2–3), pp.77–83.
Hajihosseini, M.K. 2008. Fibroblast growth factor signalling in cranial suture development and 
pathogenesis. Frontiers in Oral Biology, 12, pp.160-177
Hannezo, E. et al., 2017. A Unifying Theory of Branching Morphogenesis. Cell, 171(1), pp.242–
255.e27.
Hayashi, S. & McMahon, A.J. 20002. Efficient recombination in diverse tissues by a tamoxifen-
inducible form of cre: a tool for temporally regulated gene activation/inactivation in the 
mouse. Developmental Biology, 244; pp. 305-318
Hoegger, M.J. et al., 2014. Impaired mucus detachment disrupts mucociliary transport in a piglet 
model of cystic fibrosis. Science, 345(6198), pp.818–22.
Ianowski, J.P. et al., 2007. Mucus secretion by single tracheal submucosal glands from normal 
and cystic fibrosis transmembrane conductance regulator knockout mice. The Journal of 
Physiology, 580(Pt 1), pp.301–14.
Jaskoll, T. et al., 2005. FGF10/FGFR2b signaling plays essential roles during in vivo embryonic 
submandibular salivary gland morphogenesis. BMC Developmental Biology, 5, p.11.
Jeong, J.H. et al., 2015. Secretion rates of human nasal submucosal glands from patients with 
chronic rhinosinusitis or cystic fibrosis. American journal of rhinology & allergy, 29(5), 
pp.334–338.
Joo, N.S. et al., 2001. Optical method for quantifying rates of mucus secretion from single 
submucosal glands. American Journal of Physiology. Lung Cellular and Molecular 
Physiology, 281(2), pp.L458-68.
Joo, N.S. et al., 2010. Hyposecretion of fluid from tracheal submucosal glands of CFTR-
deficient pigs. The Journal of clinical investigation, 120(9), pp.3161–3166.
Kelly, R.G. et al., 2001. The arterial pole of the mouse heart forms from Fgf10-expressing cells 
in pharyngeal mesoderm. Developmental Cell. 1, pp.435–440. 
Keswani, S.G. et al., 2011. Submucosal gland development in the human fetal trachea xenograft 
model: implications for fetal gene therapy. Journal of Pediatric Surgery, 46(1), pp.33–8.
Klockars, M. & Reitamo, S., 1975. Tissue Distribution of Lysozyme in Man. Journal of 
Histochemistry & Cytochemistry, 23(12), pp.932–940.
Lizen, B. et al., 2015. Perinatal induction of Cre recombination with tamoxifen. Transgenic 
Research, 24, pp1065-1077.
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
Lynch, T.J. et al., 2018. Submucosal Gland Myoepithelial Cells Are Reserve Stem Cells That 
Can Regenerate Mouse Tracheal Epithelium. Cell Stem Cell, 22(5), pp.653–667.
Mailleux, A.A. et al., 2002. Role of FGF10/FGFR2b signaling during mammary gland 
development in the mouse embryo. Development, 129, pp.53–60.
Makarenkova, H.P. et al., 2000. FGF10 is an inducer and PAX6 a competence factor for lacrimal 
gland development. Development, 127, pp2563-2572.
Masson, P.L. et al., 1966. Immunohistochemical localization and bacteriostatic properties of an 
iron-binding protein from bronchial mucus. Thorax, 21(6), pp.538–44.
May, A. & Tucker, A., 2015. Understanding the development of the respiratory glands. 
Developmental Dynamics, 244(4), pp.525–539.
May, A.J. et al., 2016. FGF and EDA pathways control initiation and branching of distinct 
subsets of developing nasal glands. Developmental Biology, 419(2), pp.348–356.
May, A.J. et al., 2015. Salivary Gland Dysplasia in Fgf10 Heterozygous Mice: A New Mouse 
Model of Xerostomia. Current Molecular Medecine, pp.1–9.
Milunsky, J.M. et al., 2006. LADD syndrome is caused by FGF10 mutations. Clin Genet, 69(4), 
pp.349–354.
Min, H. et al., 1998. Fgf-10 is required for both limb and lung development and exhibits striking 
functional similarity to Drosophila branchless. Genes & Development, 12(20), pp.3156–
3161.
De Moerlooze, L. et al., 2000. An important role for the IIIb isoform of fibroblast growth factor 
receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. 
Development, 127(3), pp.483–92.
Oppenheimer, E. & Esterly, J., 1975. Pathology of cystic fibrosis: review of the literature and 
comparison with 146 autopsied cases. In H. Rosenberg & R. Bolande, eds. Perspectives in 
Pediatric Pathology. Chicago, USA: Yearbook Medical Publishers, pp. 241–278.
Ornitz, D. & Itoh, N., 2001. Fibroblast growth factors. Genome Biology, 2(3), pp.1–12.
Ramasamy, S.K. et al., 2007. Fgf10 dosage is critical for the amplification of epithelial cell 
progenitors and for the formation of multiple mesenchymal lineages during lung 
development. Developmental Biology, 307(2), pp.237–247.
Rawlins, E. et al., 2009. The Role of Scgb1a1+ Clara Cells in the Long-Term Maintenance and 
Repair of Lung Airway, but Not Alveolar, Epithelium. Cell Stem Cell, 4(6), pp.525–534.
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
Rawlins, E.L. et al., 2007. Lung development and repair: contribution of the ciliated lineage. 
Proceedings of the National Academy of Sciences of the United States of America, 104(2), 
pp.410–7.
Rawlins, E.L. & Hogan, B.L.M., 2005. Intercellular growth factor signaling and the development 
of mouse tracheal submucosal glands. Developmental Dynamics, 233(4), pp.1378–85.
Reid, L., 1960. Measurement of the bronchial mucous gland layer: a diagnostic yardstick in 
chronic bronchitis. Thorax, 15, pp.132–41.
Rock, J.R. et al., 2009. Basal cells as stem cells of the mouse trachea and human airway 
epithelium. Proceedings of the National Academy of Sciences of the United States of 
America, 106(31), pp.12771–5.
Rogers, D.F., 2004. Airway mucus hypersecretion in asthma: an undervalued pathology? Current 
Opinion in Pharmacology, 4(3), pp.241–50.
Rogers, D.F., 2008. Airway Mucus Hypersecretion in Asthma and COPD: Not the Same? In P. 
Barnes et al., eds. Asthma and COPD. Basic Mechanisms and Clinical Management. 
Academic Press Inc., pp. 211–223.
Roy, M.G. et al. 2014. Muc5b is required for airway defense. Nature. 505, pp412-416.
Sala, F.G. et al., 2011. FGF10 controls the patterning of the tracheal cartilage rings via Shh. 
Development, 138, pp.273–282.
Salinas, D. et al., 2005. Submucosal gland dysfunction as a primary defect in cystic fibrosis. 
FASEB journal : official publication of the Federation of American Societies for 
Experimental Biology, 19(3), pp.431–433.
Sekine, K. et al., 1999. Fgf10 is essential for limb and lung formation. Nature Genetics, 21(1), 
pp.138–141.
Shams, I. et al., 2007. Lacrimo-auriculo-dento-digital syndrome is caused by reduced activity of 
the fibroblast growth factor 10 (FGF10)-FGF receptor 2 signaling pathway. Mol Cell Biol, 
27(19), pp.6903–6912.
Skarnes, W.C. et al., 2011. A conditional knockout resource for the genome-wide study of mouse 
gene function. Nature, 474(7351), pp.337–344.
Steinberg Z. et al., 2005. FGFR2b signaling regulates ex vivo submandibular gland epithelial cell 
proliferation and branching morphogenesis. Development 132, pp.1223-1234.
Sturgess, J. & Imrie, J., 1982. Quantitative evaluation of the development of tracheal submucosal 
glands in infants with cystic fibrosis and control infants. The American Journal of 
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
Pathology, 106(3), pp.303–11.
Song, Y. et al., 2001. Role of aquaporin water channels in airway fluid transport, humidification , 
and surface liquid hydration. J Gen Physiol 17, pp 573-582.
Teshima, T.H.N., Lourenço, S.V. & Tucker, A.S., 2016. Multiple Cranial Organ Defects after 
Conditionally Knocking Out Fgf10 in the Neural Crest. Frontiers in physiology, 7, p.488.
Thurlbeck, W., Benjamin, B. & Reid, L., 1961. Development and distribution of the mucous 
glands in the foetal human trachea. British Journal of Diseases of the Chest, 55, pp.54–64.
Wells, K.L. et al., 2013. Dynamic relationship of the epithelium and mesenchyme during 
salivary gland initiation: the role of Fgf10. Biology open, 2(10), pp.981–989.
Xie, W. et al., 2014. Sox2 modulates Lef-1 expression during airway submucosal gland 
development. AJP: Lung Cellular and Molecular Physiology, 306(7), pp.L645–L660.
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
1050
1051
1052
1053
1054
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
Figure 1. Fgf10 is essential for successful tracheal gland branching morphogenesis.
(A) Schematic representation of the four stages of tracheal gland branching morphogenesis. Stage 
1: Tracheal SMG buds first invaginate from the respiratory epithelium into the underlying 
mesenchyme. Stage 2: Elongation of the bud occurs, and cavitation begins lumen formation. Stage 
3: Epithelial stalk undergoes clefting and branching and lumen formation continues. Stage 4: 
Continual branching and cellular differentiation occurs indicated by mucus production by acinar 
cells. (B-D) Frontal trichrome stained images of the anterior trachea at postnatal stage (P) 0. (B’-
D’) High power images of B-D. (B,B’) WT SMGs reached lumen formation and branching stages 
in the ventral trachea at P0. (C. C’) Fgf10 +/- SMGs form lumens, however branching of the glands 
was reduced. (D, D’) Gland buds were found in Fgf10 -/- mice however they had not elongated 
from the respiratory epithelium. Scale bar in B, B’= 100µm, same scale in other images. Arrows 
indicate SMGs, orange outline SMGs in higher magnification images. Cartilages stain blue with 
alcian blue.
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Figure 2. Tracheal SMG morphogenesis is inhibited with conditional ablation of Fgf10 
during postnatal SMG development.
(A) Fgf10LacZ/+ trachea at postnatal day (P) 7 stained with X‐gal (blue – arrows) to show Fgf10 
expression surrounding SMGs. (B) Time-course of tamoxifen (TMX) administration of wildtype 
(WT) and CreERT2;Fgf10fl/fl;tdTom mice. TMX was given to pregnant females at embryonic day 
(E)17.5 and individual pups on P2. Trachea were analyzed on P21. (C) Confirmation of inducible 
Cre recombination in the anterior (a) and posterior (p) trachea by the expression of R26tdTomato 
(red). (D) A significant loss in anterior SMG branching is evident in P21 Fgf10 conditional knock-
out mice adjacent to the cricoid cartilage (CC), with a reduction in SMG branch expansion into 
the mesenchyme compared to WT. Heterozygous mice showed a slight reduction in anterior SMG 
branching. (D, E) Posterior SMGs are present between the cartilage rings (C1-C4) in WT animals 
at P21, however are reduced in heterozygous and homozygous Fgf10 mutant mice. Scale bar in A 
= 100µm, C & D = 200µm. Orange outline indicates anterior  SMGs. Arrows indicate posterior 
SMGs. 
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Figure 3. Fgf10 +/- tracheal SMG phenotype is not recovered in adult animals.
(A,C) Frontal sections through adult tracheas stained with trichrome. (A) WT adults show 
extensively branched anterior SMGs adjacent to the cricoid cartilage (CC) while Fgf10 +/-
  littermates show a significant reduction in glands in a similar plane. Scale bar = 100µm. (B) 
Posterior extension of the SMGs is noticeably reduced in Fgf10 +/-  animals compared to their 
WT littermates. N numbers represent each specimen analysed while pink bars represent 
mesenchymal space where SMGs are found between each cartilage ring (C1-C8). X indicates 
presence of SMG. (C) No obvious differences were observed in the tracheal epithelium of adult 
WT and Fgf10 +/-  littermates at 6-10 weeks. Scale bar in A, C = 50µm.
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Figure 4. Fgf10 +/- adult mice have fewer tracheal SMGs and an overall reduction in mucus 
secretion.
(A) Visualisation of functional gland openings in WT (n=4) and Fgf10 +/- (n=6) anterior tracheal 
tissue by mucus bubble production. A decrease in the number of mucus bubbles was observed in 
Fgf10 +/- mice. Scale bar = 500µm. (B) Graphical representation of mucus bubble count, showing 
a significant reduction in Fgf10+/- animals compared to their WT littermates. Average bubble area 
was similar between the two groups however overall mucus secretion into the airway lumen was 
significantly reduced in Fgf10+/- animals. *** = p < 0.001. Data in B are mean ± s.d.
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Supplementary Figure 1.
(A) WT and Fgf10 +/- show no differences in tracheal cartilage ring patterning at E18.5. (B) 
Schematic representation of dissection protocol carried out on adult tracheal tissue in preparation 
for mucus production analysis. Axis labels: anterior (A); posterior (P); ventral (V), dorsal (D): left 
(L); right (R). (C) For mucus secretion analysis, tracheal tissue was flattened out and pinned down 
onto a sylgard plate, exposing the mucosal side. DMEM F/12 medium was added underneath the 
tissue, while mineral oil was added on top of the mucosal side and gland openings. After 10 
minutes of incubation, carbachol was added to the medium bath. Mucus bubble production was 
observed and recorded for 10 minutes. 
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